Sharemaestro Newsreel

Addus HomeCare sets Q2FY26 earnings release date

Addus HomeCare Corporation announced it will release its financial results for the second quarter ended June 30, 2026, on August 3, 2026, after market close. A conference call featuring senior leadership, including CEO Dirk Allison and CFO Brian Poff, is scheduled for August 4, …

Will Higher Expenses Impact HCA Healthcare's Q2 Earnings?

HCA Healthcare is scheduled to report its second-quarter 2026 earnings on July 24, 2026. While the company is projected to see year-over-year growth in earnings and revenue, increased operating expenses, particularly in salaries, benefits, and supply costs, alongside a potential decline in average length …

Addus HomeCare publishes update to financial calendar

Addus HomeCare has announced an update to its financial calendar. The company is set to release its Q2 2026 earnings on August 3, 2026, after the market closes. Management will further discuss these results on an earnings conference call scheduled for 9:00 a.m. ET …

Does Acadia Healthcare (ACHC) Joining the Russell 2000 Reframe Its Behavioral Health Investment Narrative?

Acadia Healthcare (ACHC) was moved from the Russell 1000 to the Russell 2000 Index, recategorizing it into the smaller-capitalization value universe. This shift is primarily technical, influencing its investor base and trading liquidity, but its impact on the company's fundamentals is less significant than …

SONS stock trades steadily as Sonida Senior Living focuses on occupancy and cash flow

Sonida Senior Living (SONS) focuses on improving occupancy rates, operating margins, and liquidity management to drive its turnaround. Recent reports show improved occupancy and adjusted EBITDA, though the company continues to manage net losses and a significant debt burden. The stock's performance is tied …

Acadia Healthcare Company (ACHC) Proxy filing Summary

Acadia Healthcare Company (ACHC) has released its proxy filing summary for the annual meeting scheduled for May 6, 2026. Key proposals include electing three Class III directors, amending the incentive compensation plan to increase available shares, holding a non-binding advisory vote on executive compensation, …

Acadia Healthcare Company (ACHC) Barclays 28th Annual Global Healthcare Conference summary

Acadia Healthcare Company (ACHC) presented at Barclays' 28th Annual Global Healthcare Conference, highlighting leadership changes and an energized focus on patient care and operational execution, including filling 3,000 new beds. The company detailed a $200 million embedded EBITDA opportunity from underperforming new facilities due …

Kaplan Fox Alerts The Ensign Group, Inc. (ENSG) Investors to an Investigation of Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. (ENSG) following a report by Hunterbrook Media alleging inadequate care and systematic misrepresentations. The report, titled "Ensign: The Nursing Home Empire Built On Fatal Neglect," caused Ensign's stock price …

Addus HomeCare Announces Second Quarter 2026 Earnings Release and Conference Call

FRISCO, Texas, July 20, 2026--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the second quarter ended June 30, 2026, on Monday, August 3, 2026, after the market close. Addus HomeCare will host …

Concentra’s Boise center will offer work injury care and drug testing

Concentra, a national leader in occupational and workforce health services, is opening its first Idaho medical center in Boise on July 22. This expansion aims to provide comprehensive workforce health solutions, including work injury care, drug testing, and physical exams, to employers and employees …

CMPS stock trades steadily as Compass Pathways expands psilocybin depression program

Compass Pathways' CMPS stock is closely tied to its progress in developing psilocybin therapy for treatment-resistant depression, with investors monitoring trial milestones, cash reserves, and Nasdaq trading performance. The company, a clinical-stage biotech, has no commercial revenue but emphasizes its cash position and R&D …

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings and 25% Upside Potential

Tenet Healthcare Corporation (THC) is attracting investor interest with strong buy ratings and a potential 25% upside. Despite a recent slight dip, the company, valued at $16.79 billion, shows financial strength with a 30.29% return on equity and substantial free cash flow. Analysts are …

Ensign Group (ENSG) insider Agwunobi plans 392-share NASDAQ stock sale

Ensign Group insider John O. Agwunobi has filed a notice to sell 392 common shares of ENSG stock through Fidelity Brokerage Services LLC on NASDAQ on July 20, 2026, with an estimated value of $67,055.52. The filing also detailed restricted stock vesting events totaling …

Fresenius Medical Care stock trades steady as dialysis group highlights margin recovery and stable c

The article discusses Fresenius Medical Care stock, focusing on the company's efforts to highlight margin recovery and stable cash flow in its dialysis business. It delves into revenue and earnings trends, margin comparisons, segment performance, balance sheet strength, and the impact of restructuring initiatives. …

DaVita stock holds firm as earnings and cash flow support dialysis strategy

DaVita Inc. (ISIN US23918K1088) demonstrates a stable business model focused on dialysis services, reporting $11.6 billion in annual revenue and improved profitability. The company's financial health is supported by strong operating cash flow of $1.8 billion, which is used for debt reduction and significant …

Tenet Healthcare Q2 2026 Earnings Preview — July 24, Street Expects $4.26 EPS

Tenet Healthcare Corporation (NYSE:THC) is set to release its Q2 2026 earnings on July 24, with analysts anticipating $4.26 EPS on revenues of $5.44 billion. This marks a significant 35.7% increase in EPS year-over-year, driven by strong operating leverage despite a more modest 3.2% …

HCA Healthcare (HCA) Q2 2026 Preview: EPS Est. $7.47, Reports July 24

HCA Healthcare is expected to report second-quarter 2026 earnings of $7.47 per share on $19.38 billion in revenue on July 24, as estimated by a consensus of 20 analysts. The stock trades at $362.66 and investors will be watching key metrics such as patient …

Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy

Cloud-based platform provides retrospective, program-level insight into kidney replacement therapy delivered in acute and hospital critical care settings Available within NxStage® System One™ with NxView™ 4.0, Fresenius Medical Care's FDA 510(k)-cleared software platform for kidney replacement therapy in the United States Aggregates existing therapy …

1,587,636 Shares in Option Care Health, Inc. $OPCH Acquired by Van Berkom & Associates Inc.

Van Berkom & Associates Inc. has acquired a new stake of 1,587,636 shares in Option Care Health, Inc. (NASDAQ:OPCH), valued at approximately $42.7 million, representing about 1.01% ownership. Other institutional investors have also increased their holdings, with hedge funds now owning around 98.05% of …

Multiple Headwinds Hurt Option Care Health (OPCH)

Madison Small Cap Fund highlighted Option Care Health (OPCH) in its Q2 2026 investor letter, noting a difficult quarter for the company due to the loss of a profitable specialty drug, reimbursement delays, decline in therapy volume, and biosimilar-related pricing pressures. The fund exited …

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Leader Offering 27% Potential Upside

The Ensign Group, Inc. (ENSG) is a prominent healthcare provider with a $10.01 billion market cap, specializing in skilled nursing, senior living, and rehabilitative services. Analysts project a potential upside of 27.16% for ENSG, with an average target price of $217.80, driven by strong …

KBC Group NV Sells 29,838 Shares of HCA Healthcare, Inc. $HCA

KBC Group NV reduced its stake in HCA Healthcare by 7.8% in the first quarter, selling 29,838 shares and retaining 354,583 shares valued at approximately $167.8 million. HCA Healthcare reported mixed Q1 results, with EPS missing estimates slightly but revenue exceeding expectations and growing …

FMC stock trades steady as Fresenius Medical Care updates guidance and margin focus

Fresenius Medical Care (FMC) is focusing on improving profitability, with updated fiscal 2024 guidance projecting adjusted operating income growth of 5-15% despite revenue growth of only 0-3%. This strategic shift emphasizes operational efficiency, cost control, and margin expansion in its dialysis services and product …

Assetmark Inc. Grows Position in HCA Healthcare, Inc. $HCA

Assetmark Inc. significantly increased its stake in HCA Healthcare by 51.8% in the first quarter, bringing its total holdings to 32,701 shares valued at $15.5 million. Institutional investors collectively own 62.73% of HCA stock, indicating strong institutional interest. Despite some recent analyst price target …

Allspring Global Investments Holdings LLC Buys 7,807 Shares of Chemed Corporation $CHE

Allspring Global Investments Holdings LLC increased its stake in Chemed Corporation (NYSE:CHE) by 7.9% in the first quarter, purchasing 7,807 additional shares and bringing its total holdings to 107,215 shares valued at $40.5 million. While institutional investors own a significant portion of Chemed, some …

Universal Health Services (UHS) Expected to Announce Earnings on Monday

INNV Q2 2026 Earnings: Massive EPS Miss Sends Shares Lower - Earnings Cycle Report

Addus HomeCare schedules Q2 results after close, call next morning

Auna S.A. announces Q2 2026 earnings release date for August 18

Is Concentra (CON) Using Targeted Clinic Openings to Validate Its Integrated Telemed Strategy?

Concentra Group Holdings Parent recently expanded its services by opening a new medical center near Kansas City International Airport, integrating on-site care with its Concentra Telemed platform. This move supports the company's strategy of combining clinic capabilities with telemedicine to enhance employer convenience and …

Brookdale Senior Living acquires previously managed community in Houston for $23.4M

Brookdale Senior Living has acquired Brookdale Galleria, a 244-unit independent and assisted living community in Houston, for $23.4 million. The company, which previously managed the property, funded the acquisition using cash and its expanded line of credit. CEO Nick Stengle stated the purchase represents …

agilon health (AGL) Proxy filing Summary

agilon health (AGL) has released its proxy filing summary, detailing the upcoming annual meeting on June 2, 2026. Shareholders will vote on electing three Class II directors, ratifying Ernst & Young LLP as auditor, and an advisory vote on executive compensation, all of which …

Pennant Group (PNTG) director receives 1,900-share stock grant

Pennant Group (PNTG) director Stephen M R Covey was granted 1,900 shares of common stock on July 15, 2026, as equity compensation. These shares, valued at $0.00 per share, will vest in three annual installments starting July 15, 2027. Following this grant, Covey's direct …

Knox Lane Completes Acquisition of Cross Country Healthcare

Knox Lane has completed its acquisition of Cross Country Healthcare, a technology-enabled healthcare workforce solutions company. Concurrently, Joel Tremblay has been appointed CEO of Cross Country Healthcare, succeeding Kevin C. Clark. This acquisition marks a new phase for Cross Country Healthcare as a privately …

Concentra Group Holdings Parent, Inc. (CON) Gets a Buy from Goldman Sachs

Goldman Sachs analyst Scott Fidel maintained a Buy rating on Concentra Group Holdings Parent, Inc. (CON) with a $34.00 price target. The analyst consensus for CON is a Strong Buy with an average price target of $33.57, indicating an 8.64% upside. Despite positive analyst …

Does Tenet Healthcare (THC) Still Sit Below Fair Value Today?

Tenet Healthcare (THC) appears undervalued, trading at a P/E ratio of 9.9x compared to an industry average of 26.0x and an estimated fair P/E of 19.0x. Despite a 172.1% total return over the past five years, valuation checks suggest the stock is still inexpensive …